How Much Did YPrime Raise?
Funding & Key Investors

YPrime, a provider of clinical trial data management solutions, has secured significant capital, with its total funding reaching $18.6M. The company recently announced a major strategic investment of $2M, underscoring its continued growth and market position in the biopharmaceutical technology sector. This latest financing round signals a pivotal moment for YPrime as it aims to further enhance its offerings and expand its operational reach.

What is YPrime?

YPrime
SoftwareHealthcare SoftwareBusiness Services

Founded in 2006 and headquartered in Malverne, Pennsylvania, YPrime specializes in software solutions and consulting services designed to streamline clinical trial data collection and information management. The company serves biopharmaceutical firms and contract research organizations, facilitating more efficient and collaborative research processes. YPrime's technology addresses critical needs in the complex landscape of clinical research, enabling better data integrity and faster trial progression.

How much funding has YPrime raised?

YPrime has raised a total of $18.6M across 6 funding rounds:

2013

Private Equity

$5M

2014

Private Equity

$2.5M

2016

Private Equity

$2M

Debt

$5M

2017

Private Equity

$2.1M

2020

Debt

$2M

Private Equity (2013): $5M, investors not publicly disclosed

Private Equity (2014): $2.5M, investors not publicly disclosed

Private Equity (2016): $2M, investors not publicly disclosed

Debt (2016): $5M featuring Square 1 Bank

Private Equity (2017): $2.1M, investors not publicly disclosed

Debt (2020): $2M with participation from PPP

Key Investors in YPrime

Square 1 Bank

Square 1 Bank, a division of Pacific Western Bank, is a financial services partner for entrepreneurs and investors, offering venture debt and treasury solutions. Their focus on innovation centers supports companies in their growth phases.

PPP

Public-Private Partnership

What's next for YPrime?

The recent major strategic investment positions YPrime for accelerated development and market penetration. This capital infusion is expected to fuel advancements in its platform, potentially expanding into new therapeutic areas or enhancing its analytics capabilities. The company's focus on collaborative data management in clinical trials aligns with the growing demand for digital transformation in the life sciences industry, suggesting a trajectory towards further scaling and innovation. YPrime's strategic financing indicates a strong confidence in its business model and its capacity to capture a larger share of the clinical trial technology market.

See full YPrime company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
SoftwareSupply Chain Management (SCM) SoftwareBusiness Intelligence (BI) Software
Engineering SoftwareSoftwareMultimedia, Games & Graphics Software
Financial SoftwareSoftwareMobile App Development

Frequently Asked Questions Regarding YPrime Financial Insights

What are the most recent funding rounds that YPrime has completed, and what were the funding rounds?
YPrime has recently completed 3 funding rounds: Debt on Apr 9, 2020, Private Equity on Oct 24, 2017, Debt on Jun 13, 2016.
What is the total amount of funding YPrime has raised to date?
YPrime has raised a total of $18.6M in funding to date.
How many funding rounds has YPrime completed?
YPrime has completed 3 funding rounds.
How much funding did YPrime raise in its most recent funding round?
YPrime raised $2M in its most recent funding round.
Who are the lead investors in YPrime's latest funding round?
The lead investor in YPrime's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in YPrime's history?
The largest funding round in YPrime's history was $5M.
See more information about YPrime